Evidence map›Paper›PMID 31551755›Full record

ArticleFrontiers in aging neuroscience2019

Novel Functions of the Neurodegenerative-Related Gene Tau in Cancer.

Ricardo Gargini, Berta Segura-Collar, Pilar Sánchez-Gómez

Open access · goldAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Genes · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Tau Isoforms: Gaining Insight intoInternational journal of molecular sciences · 2022
    Review
  19. Review
  20. The road-map for establishment of a prognostic molecular marker panel in glioma using liquid biopsy: current status and future directions.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Ricardo GarginiCentro de Biología Molecular, CSIC, Madrid, Spain.
Berta Segura-CollarNeurooncology Unit, Instituto de Salud Carlos III-UFIEC, Madrid, Spain.
Pilar Sánchez-GómezNeurooncology Unit, Instituto de Salud Carlos III-UFIEC, Madrid, Spain.
Centro de Biología Molecular Severo Ochoa · ESInstituto de Salud Carlos III · ESUnidad Funcional de Investigación de Enfermedades Crónicas · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The analysis of global and comparative genomics between different diseases allows us to understand the key biological processes that explain the etiology of these pathologies. We have used this type of approach to evaluate the expression of several neurodegeneration-related genes on the development of tumors, particularly brain tumors of glial origin (gliomas), which are an aggressive and incurable type of cancer. We have observed that genes involved in Amyotrophic lateral sclerosis (ALS), as well as in Alzheimer's and Parkinson's diseases, correlate with better prognosis of gliomas. Within these genes, high

Indexed as

cancergliomasneurodegenerative diseasesTau/MAPTtumor aggressiveness

Identifiers

PMID31551755
PMCPMC6736573
OpenAlexW2967572416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.